GO:0140739 NLRP6 inflammasome complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140739 describes the biological process by which NLRP6, ASC and caspase-1 assemble into a functional inflammasome complex.
• NLRP6 is an innate immune sensor that oligomerizes upon ligand or danger signal recognition, recruiting ASC via pyrin domain interactions and caspase-1 via CARD interactions [1,2].
• NLRP6 inflammasome assembly is critical for IL-18 and IL-1beta maturation, mucus secretion, and gut microbiota homeostasis [2,3].
• Dysregulated NLRP6 assembly is linked to inflammatory bowel disease, colorectal cancer, and metabolic disorders [2,3,7].
• Tissue-selective alternate promoters regulate NLRP6 expression, influencing inflammasome assembly in a cell-type-specific manner.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting NLRP6 inflammasome assembly mechanisms and therapeutic potential [3,4].
Description
The NLRP6 inflammasome complex assembly (GO:0140739) is a biological process that governs the aggregation, arrangement, and bonding of NLRP6, ASC, and caspase-1 into a multimeric signaling platform. This process is a cornerstone of innate immunity, enabling host cells to detect microbial patterns and danger signals and to mount inflammatory responses through cytokine maturation and pyroptosis [2,4]. NLRP6 is highly expressed in intestinal epithelial cells and immune cells, where its assembly is tightly regulated to maintain tissue homeostasis [2,8]. Understanding the molecular steps of NLRP6 inflammasome assembly is essential for researchers studying mucosal immunity, inflammatory diseases, and host-microbiota interactions [3,7]. The assembly process is initiated by ligand sensing, followed by NLRP6 oligomerization, ASC speck formation, and caspase-1 activation. Each step offers potential targets for therapeutic intervention and experimental modeling using CRISPR-based gene editing [3,4].
NLRP6 inflammasome complex assembly At A Glance
| GO ID | GO:0140739 |
|---|---|
| GO term | NLRP6 inflammasome complex assembly |
| Ontology | biological_process |
| Synonym | None |
| Major function | Assembly of a multiprotein inflammasome complex that activates caspase-1 and promotes IL-18/IL-1beta maturation [1,2] |
| Key components | NLRP6, ASC (PYCARD), caspase-1 (CASP1) |
| Cellular location | Cytosol, associated with membranes and mitochondria |
| Regulatory mechanism | Tissue-selective alternate promoters and epigenetic regulation [5,8] |
| Disease relevance | Inflammatory bowel disease, colorectal cancer, metabolic syndrome [2,3,7] |
What Is GO:0140739?
GO:0140739, NLRP6 inflammasome complex assembly, is defined as the aggregation, arrangement, and bonding together of a set of components to form a NLRP6 inflammasome complex. In practice, this involves the self-association of NLRP6 monomers, recruitment of the adaptor protein ASC (PYCARD), and subsequent activation of caspase-1, leading to the formation of a functional inflammasome platform [1,2].
Why Is NLRP6 inflammasome complex assembly Important in Cell Biology?
NLRP6 inflammasome complex assembly is a central node in innate immunity and mucosal homeostasis. Its dysregulation contributes to chronic inflammation, tumorigenesis, and metabolic disorders, making it a high-priority target for mechanistic studies and therapeutic development [2,3,7]. Understanding the assembly process at the molecular level can reveal new biomarkers and intervention points for diseases such as inflammatory bowel disease and colorectal cancer [3,7].
• Maintains intestinal barrier integrity by regulating mucus secretion and antimicrobial peptide production.
• Controls gut microbiota composition through IL-18-dependent pathways [2,3].
• Protects against colitis and colitis-associated colorectal cancer in experimental models [2,7].
• Modulates metabolic inflammation and insulin resistance in obesity.
• Serves as a sensor for viral and bacterial ligands, contributing to host defense [1,4].
• Its assembly is regulated by epigenetic mechanisms, linking environment to immune responses.
• Tissue-specific expression via alternate promoters affects inflammasome activity in different organs.
• Provides a paradigm for studying other NLRP inflammasomes, such as NLRP3 and NLRP12 [4,6].
• Offers potential targets for anti-inflammatory drug discovery.
• Enables CRISPR-based functional genomics to identify novel regulators of inflammasome assembly [3,4].
What Happens During NLRP6 inflammasome complex assembly?
Ligand sensing and NLRP6 activation
In simple terms: NLRP6 detects danger signals or microbial molecules, which triggers it to change shape and get ready to assemble.
NLRP6 senses a variety of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), including bacterial lipoteichoic acid and viral RNA [1,4]. Upon ligand binding, NLRP6 undergoes a conformational change that exposes its pyrin domain (PYD), enabling self-oligomerization. This initial activation step is critical for downstream assembly and is regulated by tissue-specific expression patterns.
NLRP6 oligomerization and ASC recruitment
In simple terms: Activated NLRP6 molecules stick together and recruit the adaptor protein ASC to form a platform.
Activated NLRP6 monomers oligomerize through homotypic PYD-PYD interactions, forming a nucleation seed. The PYD of NLRP6 then recruits ASC (encoded by PYCARD) via PYD-PYD interactions, leading to ASC polymerization into a large speck [1,2]. This step is essential for bridging NLRP6 to caspase-1 and is a key checkpoint in inflammasome assembly.
Caspase-1 recruitment and activation
In simple terms: ASC brings caspase-1 molecules together, causing them to activate and become ready to cut inflammatory proteins.
ASC recruits procaspase-1 through CARD-CARD interactions, forming a ternary complex. The proximity-induced activation of caspase-1 leads to its autoproteolytic cleavage and generation of active p20/p10 heterodimers [1,2]. Active caspase-1 then cleaves pro-IL-18 and pro-IL-1beta into their mature forms, which are secreted to propagate inflammation [2,4].
Inflammasome speck formation and signaling
In simple terms: The assembled complex forms a dense speck that serves as a signaling hub for inflammation.
The NLRP6-ASC-caspase-1 complex condenses into a single large speck per cell, which is a hallmark of inflammasome activation. This speck acts as a platform for cytokine processing and pyroptosis induction. Speck formation is dynamic and regulated by post-translational modifications and epigenetic factors.
Termination and regulation of assembly
In simple terms: The cell has ways to shut down the inflammasome to prevent excessive inflammation.
NLRP6 inflammasome assembly is negatively regulated by autophagy, ubiquitination, and interacting proteins such as NLRP12 [4,6]. Epigenetic mechanisms, including DNA methylation and histone modifications, also modulate NLRP6 expression and assembly. Proper termination is crucial to avoid chronic inflammation and tissue damage [2,3].
Key Genes Involved in GO:0140739 NLRP6 inflammasome complex assembly
The following genes and proteins are central to NLRP6 inflammasome complex assembly and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP6 | Core sensor and scaffold; oligomerizes upon activation | Knockout models show impaired IL-18 production and altered microbiota [1,2] |
| PYCARD (ASC) | Adaptor protein linking NLRP6 to caspase-1 | Essential for speck formation; knockout abolishes inflammasome function |
| CASP1 | Effector protease; cleaves pro-IL-18 and pro-IL-1beta | Activity readout for inflammasome assembly [1,2] |
| IL18 | Pro-inflammatory cytokine processed by caspase-1 | Key effector of NLRP6-mediated mucosal immunity |
| IL1B | Pro-inflammatory cytokine processed by caspase-1 | Marker of inflammasome activation in disease models [2,3] |
| NLRP3 | Related inflammasome sensor; can interact with NLRP12 | Comparative studies reveal shared assembly mechanisms [4,6] |
| NLRP12 | Negative regulator of NLRP3 and potentially NLRP6 | Interacts with NLRP3 to block activation; may cross-regulate NLRP6 |
| ATG5 | Autophagy protein; regulates inflammasome degradation | Autophagy deficiency enhances NLRP6 assembly |
| ATG16L1 | Autophagy component; linked to Crohn's disease | Risk variant affects inflammasome regulation |
| CARD8 | Caspase-1 inhibitor; modulates inflammasome activity | Potential regulator of NLRP6 assembly |
| TXNIP | Redox protein; interacts with NLRP3 and possibly NLRP6 | Links oxidative stress to inflammasome activation |
| NFKB1 | Transcription factor driving NLRP6 expression | Inflammatory signaling upstream of assembly |
| STAT3 | Transcription factor modulating NLRP6 expression | Linked to colitis-associated cancer |
| IRF1 | Interferon regulatory factor; regulates inflammasome genes | Potential transcriptional regulator of NLRP6 |
| MEFV | Pyrin protein; can interact with inflammasome components | Cross-talk with NLRP6 in innate immunity |
| P2RX7 | ATP receptor; triggers NLRP3 but may affect NLRP6 | Extracellular ATP modulates inflammasome assembly |
| GSDMD | Gasdermin D; executes pyroptosis downstream of caspase-1 | Readout of NLRP6 inflammasome activation |
How Is NLRP6 inflammasome complex assembly Regulated?
NLRP6 inflammasome assembly is regulated at multiple levels. Transcriptionally, tissue-selective alternate promoters drive NLRP6 expression in a cell-type-specific manner, affecting assembly capacity. Epigenetic mechanisms, including DNA methylation and histone acetylation, modulate NLRP6 and inflammasome-related gene expression. Post-translationally, phosphorylation, ubiquitination, and autophagy control NLRP6 oligomerization and speck formation. Negative regulators such as NLRP12 and CARD8 can inhibit assembly, while positive signals from NF-kB and interferons enhance it [4,6]. This multilayered regulation ensures appropriate inflammatory responses and prevents autoinflammation [2,3].
NLRP6 inflammasome complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP6 | Inflammatory bowel disease | Nlrp6-/- mouse colitis model [2,7] |
| NLRP6 | Colorectal cancer | AOM/DSS-induced colon cancer in Nlrp6-/- mice |
| PYCARD | IBD and autoinflammation | Pycard knockout mice |
| CASP1 | Metabolic syndrome | Casp1-/- mice on high-fat diet |
| IL18 | Mucosal immunity | Il18-/- mice |
Inflammatory Bowel Disease (IBD)
NLRP6 inflammasome assembly is critical for intestinal homeostasis. Dysfunctional assembly leads to reduced IL-18 production, impaired mucus secretion, and altered microbiota, contributing to IBD pathogenesis [2,7]. Polymorphisms in NLRP6 and related genes have been associated with Crohn's disease and ulcerative colitis.
Colorectal Cancer
Chronic inflammation driven by defective NLRP6 assembly promotes colitis-associated colorectal cancer [2,3]. NLRP6 deficiency in mice increases tumor susceptibility, while intact inflammasome activity suppresses tumorigenesis through IL-18-dependent mechanisms [2,7].
Metabolic Disorders
NLRP6 inflammasome assembly influences metabolic inflammation and insulin resistance. Dysregulation is linked to obesity and non-alcoholic fatty liver disease. The assembly process modulates gut-liver axis signaling and systemic inflammation.
Infectious Diseases
NLRP6 senses viral and bacterial ligands, and its assembly is required for host defense against pathogens such as norovirus and Listeria monocytogenes [1,4]. Pathogens may evade immunity by targeting NLRP6 assembly.
From NLRP6 inflammasome complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NLRP6 oligomerization require specific PYD residues? | Point-mutation knock-in of NLRP6 PYD mutants |
| What is the role of ASC in NLRP6 assembly? | ASC knockout (PYCARD-/-) cell lines |
| How does NLRP6 expression affect colitis susceptibility? | NLRP6 overexpression in intestinal epithelial cells |
| Can we track inflammasome speck formation in real time? | Tagged knock-in of NLRP6 with fluorescent protein |
| What are the downstream effectors of NLRP6 assembly? | Caspase-1 knockout and IL-18/IL-1beta reporter cells |
| Which genes regulate NLRP6 assembly? | CRISPR library screening in macrophages [3,4] |
How to Study the NLRP6 inflammasome complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for inflammasome assembly | Identify novel regulators |
| ASC speck imaging | Inflammasome assembly efficiency | Quantify activation in live cells |
| Caspase-1 activity assay | Proteolytic activity | Measure functional assembly [1,2] |
| IL-18 ELISA | Cytokine secretion | Readout of inflammasome activation |
| Co-immunoprecipitation | Protein-protein interactions | Map NLRP6-ASC-caspase-1 complex |
| RNA-seq | Transcriptional changes | Identify pathways regulating assembly |
| Proteomics | Protein abundance and modifications | Discover post-translational regulation |
| Epigenetic profiling | DNA methylation and histone marks | Study NLRP6 expression regulation |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of NLRP6 inflammasome assembly. These screens use readouts such as caspase-1 activity or IL-18 secretion to pinpoint genes that enhance or suppress assembly [3,4].
Imaging and speck quantification
Fluorescence microscopy with ASC or NLRP6 tagging allows visualization of inflammasome speck formation. High-content imaging can quantify speck number and size as a proxy for assembly efficiency.
Biochemical assays
Co-immunoprecipitation and crosslinking studies reveal interactions between NLRP6, ASC, and caspase-1. Western blotting for caspase-1 cleavage and IL-18 maturation provides functional readouts [1,2].
Transcriptomic and proteomic profiling
RNA-seq and proteomics can map expression changes and post-translational modifications during NLRP6 assembly. These approaches identify signaling pathways and epigenetic regulators [5,8].
How CRISPR Can Be Used to Study GO:0140739 NLRP6 inflammasome complex assembly
Knockout
CRISPR knockout of NLRP6, PYCARD, or CASP1 abolishes inflammasome assembly, providing a clean background to study its role in disease models. Knockout cell lines are essential for validating specificity of assembly readouts [1,2].
Point Mutation
Point mutations in the PYD or CARD domains of NLRP6 can disrupt oligomerization or ASC recruitment. CRISPR-mediated knock-in of these mutations allows precise structure-function analysis of assembly.
Knock-in
Tagged knock-in of NLRP6 with fluorescent or affinity tags enables real-time tracking of inflammasome assembly and interactome studies. Knock-in of disease-associated variants can model human mutations [1,3].
Overexpression
Overexpression of NLRP6 or its components can drive constitutive inflammasome assembly, useful for gain-of-function studies and drug screening. Inducible overexpression systems allow temporal control.
How EDITGENE Supports NLRP6 inflammasome complex assembly Research
Researchers studying NLRP6 inflammasome complex assembly-related genes often need to determine whether a candidate gene is causally involved in assembly, cytokine maturation, or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for NLRP6 inflammasome complex assembly research.
Frequently Asked Questions About NLRP6 inflammasome complex assembly
What is NLRP6 inflammasome complex assembly?
It is the biological process (GO:0140739) by which NLRP6, ASC, and caspase-1 aggregate to form a functional inflammasome complex that activates inflammatory cytokines [1,2].
What genes are involved in NLRP6 inflammasome complex assembly?
Key genes include NLRP6, PYCARD (ASC), and CASP1, along with regulators such as NLRP12, ATG5, and IL18 [1,2,4,6].
What is the GO ID for NLRP6 inflammasome complex assembly?
The GO ID is GO:0140739, classified under biological_process.
How is NLRP6 inflammasome assembly activated?
It is activated by sensing PAMPs and DAMPs, leading to NLRP6 oligomerization, ASC recruitment, and caspase-1 activation [1,4].
What diseases are associated with NLRP6 inflammasome dysfunction?
Dysregulation is linked to inflammatory bowel disease, colorectal cancer, metabolic disorders, and increased susceptibility to infections [2,3,7].
What experimental models are used to study NLRP6 inflammasome assembly?
Common models include Nlrp6-/- mice, CRISPR knockout cell lines, and tagged knock-in reporters for imaging [1,2,3].
How does NLRP6 regulate gut microbiota?
NLRP6 inflammasome assembly promotes IL-18 secretion, which maintains antimicrobial peptide production and mucus barrier integrity, shaping microbiota composition [2,3].
Can CRISPR be used to study NLRP6 inflammasome assembly?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise dissection of assembly mechanisms and regulator discovery [3,4].
What are the key steps in NLRP6 inflammasome assembly?
The steps are ligand sensing, NLRP6 oligomerization, ASC recruitment, caspase-1 activation, and speck formation.
Why is NLRP6 inflammasome assembly important for immunity?
It is essential for cytokine maturation, host defense against pathogens, and maintenance of intestinal homeostasis [2,4].
Conclusion
NLRP6 inflammasome complex assembly (GO:0140739) is a fundamental biological process that bridges innate immune sensing to inflammatory cytokine production and mucosal homeostasis. Its molecular steps, from ligand sensing to speck formation, are tightly regulated and have profound implications for diseases such as IBD, colorectal cancer, and metabolic disorders [1,2,3,7]. Continued research using CRISPR-based models and advanced screening technologies will uncover new therapeutic targets and deepen our understanding of inflammasome biology [3,4].
References
- 1. Shen C et al.. 2019. Molecular mechanism for NLRP6 inflammasome assembly and activation.. Proc Natl Acad Sci U S A 116(6):2052-2057 PMID: 30674671
- 2. Ghimire L et al.. 2020. The NLRP6 inflammasome in health and disease.. Mucosal Immunol 13(3):388-398 PMID: 31988468
- 3. Li R et al.. 2022. The latest breakthrough on NLRP6 inflammasome.. Precis Clin Med 5(3):pbac022 PMID: 36211635
- 4. Dubey SR et al.. 2025. Molecular mechanisms and regulation of inflammasome activation and signaling: sensing of pathogens and damage molecular patterns.. Cell Mol Immunol 22(11):1313-1344 PMID: 41062723
- 5. Poli G et al.. 2020. Epigenetic Mechanisms of Inflammasome Regulation.. Int J Mol Sci 21(16) PMID: 32796686
- 6. Coombs JR et al.. 2024. NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome.. Sci Signal 17(820):eabg8145 PMID: 38261657
- 7. Kim JM. 2011. [Inflammatory bowel diseases and inflammasome].. Korean J Gastroenterol 58(6):300-10 PMID: 22198227
- 8. Bracey NA et al.. 2021. Tissue-selective alternate promoters guide NLRP6 expression.. Life Sci Alliance 4(3) PMID: 33376129
